MEA Digital Pathology Market

MEA Digital Pathology Market Size (2023 to 2028)

The digital pathology market size in the Middle East and Africa is predicted to grow USD 65.01 million by 2028 from USD 40.25 million in 2023, witnessing a CAGR of 10.06% during the forecast period.

Digital pathology is defined as an image-based information environment for managing, analyzing, and interpreting the information achieved from a digital slide. In short, the digitalization of conventional pathology labs is referred to as digital pathology. This technology has gained momentum in the medical and healthcare industry, owing to its improvements in several applications such as drug discoveries and their development, multi-functionalities in instruments, diagnostic tests, and other research applications.

Y-O-Y rise in cancer incidences, increasing teleconsultations, high efficiency of digital pathology systems, increased adoption rate, increasing government and industry player’s initiatives are paving the way for the overall growth of the MEA digital pathology market.

In addition, the rising need for integrated healthcare facilities, which can be achieved through establishing digital pathology systems, would offer profitable growth opportunities for the service providers if they can overcome threats like the high cost of installing new technology or infrastructure.

On the other hand, factors such as stringent regulatory concerns for primary diagnosis, the nonexistence of standard guidelines for digital pathology, lack of reimbursement, and skilled personnel are significant factors likely to restrain the digital pathology market growth in the MEA region.

This research report on the MEA digital pathology market has been segmented and sub-segmented into the following categories:

By Type: 

• Human Digital Pathology
• Animal Digital Pathology

By Product: 

• Scanners
• Software
• Communication Systems
• Storage Systems

By Application: 

• Teleconsultation
• Diseases Diagnosis
• Drug Discovery
• Training
• Education

By End User: 

• Pharmaceutical Companies
• Hospitals
• Academic Institutions

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, rapid urbanization, rising disposable income, and increased awareness campaigns in the MEA region are expected to drive demand for digital pathology during the forecast period. Pathologists are essential in completing laboratory tests that are necessary for disease diagnosis. However, there is now a gap between supply and demand for pathologists, particularly in Africa. In addition, because of the rising prevalence of cancer, which affects a vast population, the MEA healthcare industry has significantly impacted the market.

Additionally, rising desire for novel treatment alternatives, improved patient care facilities, and lower laboratory costs are likely to fuel demand. The primary contributors to this dominance include continuous R&D investments, supporting government initiatives relating to developing technologically sophisticated systems, growing digital imaging use, and significant players' existence.

Increased use of digital pathology for disease detection and favorable reimbursement regulations in South Africa is projected to promote regional expansion by improving the quality of cancer diagnosis. In addition, the integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation, which enhances the safety, quality, and efficiency of disease diagnoses in pathology laboratories, also boosts the use of digital pathology in disease diagnosis.

KEY MARKET PLAYERS:

A few of the leading companies in the MEA Digital Pathology Market profiled in this report are Perkin Elmer, Inc., Definiens AG, Sectra AB, Koninklijke Philips N.V, GE Healthcare, Inspirata Co., Ventana Medical Systems, Inc., Leica Biosystems, 3D-Histech Ltd, Hamamatsu Photonics K.K., Digipath Co., ZEISS, Olympus Corporation, Yokogawa Electronics Corporation, and Quorum Technologies Inc.